Gevorg Tamamyan: We Can Do More…
FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
How Sir Cliff Richard Beat Prostate Cancer at 85 and Why He’s Calling for National Screening
David OMalley: Promising Results From GOG 3026 Trial in Low-Grade Serous Ovarian Cancer
Servier Pharmaceuticals Welcomes Servier México Team to U.S. Office to Advance Strategic Alignment
Ankyra Therapeutics Appoints Sailaja Battula, PhD, as Chief Scientific Officer
SPCC Launches On Demand CME Webinars for the Definitive Trial Project
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer
The Highlights of ASH in the Mediterranean, Middle East, and North Africa is a two-day program co-hosted by the American Society of Hematology (ASH) and the Turkish Society of Hematology. […]
The 33rd Annual International Conference of the Indian Association of Palliative Care (IAPCON 2026) will be held from 13–15 February 2026 at the National Institute for Micro, Small, and Medium […]
The SITC Clinical Immuno-Oncology Network (SCION) Workshop is an intimate, intensive clinical trial development program organized by the Society for Immunotherapy of Cancer (SITC), designed to address the unique challenges […]
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a […]
The Targeted Therapies of Lung Cancer (TTLC) 2026 Meeting, organized by the International Association for the Study of Lung Cancer (IASLC), is a premier event for experts dedicated to advancing […]
The AACR IO Conference 2026, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy, will take place from February 18–21, 2026, at JW Marriott Los Angeles L.A. Live. […]
The 2026 International Cancer Neuroscience Symposium, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley's Advanced Portfolio, is a three-day dynamic hybrid event scheduled […]
The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key […]
The Advocates Webinar: Modernizing Oncology Endpoints, hosted virtually by Friends of Cancer Research (Friends), is a free, advocates-focused session scheduled for Thursday, February 19, 2026, from 12:00 PM to 1:00 PM ET. The webinar will build upon the public meeting held earlier in the month, focusing on translating complex scientific and policy discussions into accessible, […]
The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME, scheduled for February 20th – 21st, 2026, at the Circa Resort and Casino in Las Vegas, Nevada. The summit is specifically tailored for Advanced Practice Providers (APPs), including Nurse Practitioners (NPs), Physician Assistants (PAs), […]
The Highlights in GI Oncology conference, hosted by Horizon CME, is a two-day educational program providing the latest science and practice-changing advances from the world's premier GI oncology event, the ASCO Gastrointestinal Cancers Symposium. The CME initiative, designed for a multidisciplinary audience including oncologists, surgeons, and nurses, is scheduled for February 20–21, 2026, at the […]
The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders, managers, administrators, and directors in oncology. Scheduled for February 20–21, 2026, at the Circa Resort and Casino in Las Vegas, the forum focuses on equipping APP leaders with the knowledge and skills to […]